LOXL1 and breast carcinoma: Jeong YJ et al. conducted immunohistochemical staining of primary breast cancer tissue and found that the LOXL1 expression level is correlated with intratumoural inflammation and interleukin-4 (IL-4) levels, suggesting a potential immunomodulatory role for LOXL1 50.